Investing.com - Biora Therapeutics reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Biora Therapeutics announced earnings per share of $-0.030 on revenue of $80K. Analysts polled by Investing.com anticipated EPS of $-0.080 on revenue of $100K.
Biora Therapeutics shares are down 81% from the beginning of the year and are trading at $0.295 , down-from-52-week-high.
Biora Therapeutics shares gained 4.98% in after-hours trade the report.
Biora Therapeutics follows other major Healthcare sector earnings this month
Biora Therapeutics's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar